Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-27 4:12 pm Purchase | 2026-05-17 | 13D | STABLECOIN DEVELOPMENT CORPORA SDEV | Sky Frontier Foundation | 3,009,502 9.900% | 3,009,502![]() (New Position) | Filing History |
| 2026-05-22 4:39 pm Purchase | 2026-05-17 | 13G | STABLECOIN DEVELOPMENT CORPORA SDEV | Tether Global Investments Fund, S.I.C.A.F., S.A. | 3,009,502 9.990% | 3,009,502![]() (New Position) | Filing History |
| 2026-05-19 9:04 pm Purchase | 2026-05-17 | 13D | STABLECOIN DEVELOPMENT CORPORA SDEV | Framework Ventures IV L.P. | 32,715,086 46.400% | 10,562,391![]() (+47.68%) | Filing History |
| 2026-05-19 9:02 pm Purchase | 2026-05-17 | 13D | STABLECOIN DEVELOPMENT CORPORA SDEV | R01 Fund LP | 37,548,058 50.300% | 11,276,535![]() (+42.92%) | Filing History |
| 2026-04-30 4:28 pm Purchase | 2026-04-29 | 13D | STABLECOIN DEVELOPMENT CORPORA SDEV | R01 Fund LP | 26,271,523 52.800% | 10,791,479![]() (+69.71%) | Filing History |
| 2026-04-30 4:25 pm Purchase | 2026-04-29 | 13D | STABLECOIN DEVELOPMENT CORPORA SDEV | Framework Ventures IV L.P. | 22,152,695 44.500% | 10,791,479![]() (+94.99%) | Filing History |
| 2026-04-02 9:44 pm Purchase | 2026-03-31 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | R01 Fund LP | 15,480,044 58.100% | 4,118,828![]() (+36.25%) | Filing History |
| 2026-03-11 1:27 pm Purchase | 2025-10-20 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | Poplar Point Capital Management LLC | 1,020,300 0.810% | 816,240![]() (+400.00%) | Filing History |
| 2026-01-29 7:38 pm Purchase | 2025-10-21 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | Lazar David E. | 1,277,600 4.990% | 977,184![]() (+325.28%) | Filing History |
| 2026-01-21 8:12 pm Unchanged | 2026-01-16 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | Framework Ventures IV L.P. | 11,361,216 45.000% | 0 (Unchanged) | Filing History |
| 2026-01-21 8:11 pm Unchanged | 2026-01-16 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | R01 Fund LP | 11,361,216 45.000% | 0 (Unchanged) | Filing History |
| 2025-10-20 9:42 pm Purchase | 2025-10-16 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | R01 Fund LP | 11,361,216 45.100% | 11,128,393![]() (+4779.77%) | Filing History |
| 2025-10-20 9:42 pm Purchase | 2025-10-16 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | Framework Ventures IV L.P. | 11,361,216 45.100% | 11,128,393![]() (+4779.77%) | Filing History |
| 2025-10-17 5:29 pm Purchase | 2025-10-16 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | Lazar David E. | 300,416 19.990% | 60,406![]() (+25.17%) | Filing History |
| 2025-10-17 5:10 pm Unchanged | 2025-10-15 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | Poplar Point Capital Management LLC | 204,060 17.520% | 0 (Unchanged) | Filing History |
| 2025-10-15 8:29 pm Purchase | 2025-10-09 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | R01 Fund LP | 232,823 16.200% | 232,823![]() (New Position) | Filing History |
| 2025-10-15 8:28 pm Purchase | 2025-10-09 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | Framework Ventures IV L.P. | 232,823 16.200% | 232,823![]() (New Position) | Filing History |
| 2025-09-04 7:21 pm Unchanged | 2025-09-03 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | Poplar Point Capital Management LLC | 204,060 17.520% | 0 (Unchanged) | Filing History |
| 2025-08-26 4:11 pm Purchase | 2025-08-19 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | Lazar David E. | 240,010 19.990% | 240,010![]() (New Position) | Filing History |
| 2025-06-04 12:46 pm Purchase | 2025-06-03 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | Poplar Point Capital Management LLC | 204,060 17.540% | 9,729![]() (+5.01%) | Filing History |
